Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

TBTC Study 31: Rifapentine-containing Tuberculosis Treatment Shortening Regimens (S31/A5349)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02410772
Recruitment Status : Active, not recruiting
First Posted : April 8, 2015
Last Update Posted : January 28, 2019
Sponsor:
Collaborator:
AIDS Clinical Trials Group
Information provided by (Responsible Party):
Centers for Disease Control and Prevention

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Active, not recruiting
  Estimated Primary Completion Date : April 2020
  Estimated Study Completion Date : December 2020